It must be a difficult line to walk ,when you mention confidence...

It must be a difficult line to walk ,when you mention confidence of course the CEO and Scientific staff know how everything is progressing, I too have noticed the flavour of the marketing change, not focused on primarily shareholders but a more holistic over view of BOT.. Matt had mentioned previously they didnt have to take products over the finish line they just needed them to be picked up by the Big end of the street at their start line.. 
We know there are mega Pharma companies that rely on Derma products,,, disruptive tech the likes of BOT has to be recognised and DD carried out,,it will have effect on the whole Derma Market.... I can almost feel the eyes of Big Pharma on this one...